A monocyte, monocyte derived cell or macrophage infected with an oncolytic herpes simplex virus is disclosed together with uses of such infected cells in the treatment of diseases such as cancer.

Oral health care formulation and method of preparation for the same are disclosed herein. The disclosed oral care composition includes a combination of various herbs and minerals, and may be used to maintain good oral hygiene. Further, a method of oral health care is also disclosed in the various embodiments herein.

Oral health care formulation and method of preparation for the same are disclosed herein. The disclosed oral care composition includes a combination of various herbs and minerals, and may be used to maintain good oral hygiene. Further, a method of oral health care is also disclosed in the various embodiments herein.

Oral health care formulation and method of preparation for the same are disclosed herein. The disclosed oral care composition includes a combination of various herbs and minerals, and may be used to maintain good oral hygiene. Further, a method of oral health care is also disclosed in the various embodiments herein.

The present invention relates to compositions for human consumption of tailored dietary supplements or nutraceuticals, comprised of various components including, among others, vitamins and minerals, provided in various permutations, in multiple daily doses, based on an individual's age and gender, bioavailability, and synergistic and competing properties of the components, thereby promoting general wellbeing and healthiness.

The present invention relates to compositions for human consumption of tailored dietary supplements or nutraceuticals, comprised of various components including, among others, vitamins and minerals, provided in various permutations, in multiple daily doses, based on an individual's age and gender, bioavailability, and synergistic and competing properties of the components, thereby promoting general wellbeing and healthiness.

The present invention discloses a terahertz material with therapeutic and health care effect and its preparation method and application, which includes the following raw materials in parts by weight: 15˜28 SiO.sub.2, 3˜8 Al.sub.2O.sub.3, 1˜3 selenium, 2˜5 germanium, 10˜15 Fe.sub.2O.sub.3, 35˜45 ochre, 20˜35 zinc oxide, 65˜80 CaCO.sub.3, 0.1˜0.5 rare earth palladium, 1˜10 SiO.sub.x, wherein the raw materials of components are mixed according to the above proportion, and crushing, heating to 600˜1200° C. in an oxygen free environment for 3˜8 hours, and then secondary crushing, having a fineness of 3000˜8000 mesh; and then, after crushing again and powdering processing, the fineness reaches more than 10000 mesh. After being enhanced treatment by the terahertz irradiation line, the terahertz materials with therapeutic and health care effects are obtained. They can be processed and manufactured into a variety of physiotherapy equipment, with fast action speed and stable effect on human body.

The present invention discloses a terahertz material with therapeutic and health care effect and its preparation method and application, which includes the following raw materials in parts by weight: 15˜28 SiO.sub.2, 3˜8 Al.sub.2O.sub.3, 1˜3 selenium, 2˜5 germanium, 10˜15 Fe.sub.2O.sub.3, 35˜45 ochre, 20˜35 zinc oxide, 65˜80 CaCO.sub.3, 0.1˜0.5 rare earth palladium, 1˜10 SiO.sub.x, wherein the raw materials of components are mixed according to the above proportion, and crushing, heating to 600˜1200° C. in an oxygen free environment for 3˜8 hours, and then secondary crushing, having a fineness of 3000˜8000 mesh; and then, after crushing again and powdering processing, the fineness reaches more than 10000 mesh. After being enhanced treatment by the terahertz irradiation line, the terahertz materials with therapeutic and health care effects are obtained. They can be processed and manufactured into a variety of physiotherapy equipment, with fast action speed and stable effect on human body.

The present invention provides methods of treating one or more complications of premature birth suffered by premature infants, comprising administering to the premature infant umbilical cord blood stem cells and, optionally, placental stem cells. The present invention also provides methods of combining and administering, and compositions comprising, umbilical cord blood stem cells, particularly autologous cord blood cells, and placental stem cells for the treatment of premature infants.

The present invention provides methods of treating one or more complications of premature birth suffered by premature infants, comprising administering to the premature infant umbilical cord blood stem cells and, optionally, placental stem cells. The present invention also provides methods of combining and administering, and compositions comprising, umbilical cord blood stem cells, particularly autologous cord blood cells, and placental stem cells for the treatment of premature infants.